Relationship between serum levels of macrophage migration inhibitory factor and the activity of antineutrophil cytoplasmic antibody-associated vasculitides

Clinical Rheumatology

Volumn 25, Issue 3, 2006, Pages 368-372

  Becker, Heidemarie ^a   Maaser, Christian ^a   Mickholz, Eva ^a   Dyong, Anke ^a   Domschke, Wolfram ^a   Gaubitz, Markus ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Macrophage; Migration inhibitory factor; Vasculitis; Wegener's granulomatosis

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; MACROPHAGE MIGRATION INHIBITION FACTOR; METHOTREXATE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE;

ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GIANT CELL ARTERITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC POLYANGIITIS; POLYARTERITIS NODOSA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SARCOIDOSIS; SCORING SYSTEM; WEGENER GRANULOMATOSIS;

ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; HUMANS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MIDDLE AGED; MYELOBLASTIN; PEROXIDASE; POLYARTERITIS NODOSA; REFERENCE VALUES; SARCOIDOSIS; SERINE ENDOPEPTIDASES; TEMPORAL ARTERITIS; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 33645768761     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-005-0045-9     Document Type: Article

References (30)

1. Jennette JC, Falk RJ, Andrassy K et al (1994) Nomenclature of systemic vasculitides: Proposal of an international consensus conference. Arthritis Rheum 2:187-192
2. Hewins P, Cohen Tervaert JW, Savage COS et al (2000) Is Wegener's granulomatosis an autoimmune disease? Curr Opin Rheumatol 12:3-10
3. Weidner S, Carl M, Riess R, Rupprecht HD (2004) Histologic analysis of renal leukocyte infiltration in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 50(11):3651-3657
4. Gregersen PK, Bucala R (2003) Macrophage migration inhibitory factor, MIF alleles, and the genetics of inflammatory disorders: Incorporating disease outcome into the definition of phenotype. Arthritis Rheum 48 5:1771-1776
5. Bloom BR, Bennett B (1966). Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153:80-82
6. David JR (1966) Delayed hypersensitivity in vitro: Its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci U S A 56:72-77
7. Metz CN, Bucala R (1997) Role of macrophage migration inhibitory factor in the regulation of the immune response. Adv Immunol 66:197-223
8. Calandra T, Bernhagen J, Mitchell RA, Bucala R (1994) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 179:1895-1902
9. Yamada G, Shijubo N, Takagi-Takahashi Y et al (2002) Elevated levels of serum macrophage migration inhibitory factor in patients with pulmonary tuberculosis. Clin Immunol 2:123-127
10. Yoshida T, Siltzbach LE, Masih N, Cohen S (1979) Serum-migration inhibitory activity in patients with sarcoidosis. Clin Immunol Immunopathol 13:39-46
11. Ohwatari R, Fukuda S, Iwabuchi K et al (2001) Serum level of macrophage migration inhibitory factor as a useful parameter of clinical course in patients with Wegener's granulomatosis and relapsing polychondritis. Ann Otol Rhinol Laryngol 110:1035-1040
12. Nishihira J, Koyama Y, Mizue Y (1998) Identification of macrophage migration inhibitory factor (MIF) in human vascular endothelial cells and its induction by lipopolysaccharide. Cytokine 10:199-205
13. Chen Z, Sakuma M, Zago AC et al (2004) Evidence for a role of macrophage migration inhibitory factor in vascular disease. Arterioscler Thromb Vasc Biol 24(4):709-714
14. Lan HY, Yang N, Nikolic-Paterson DJ et al (2000) Expression of macrophage migration inhibitory factor in human glomerulonephritis. Kidney Int 57:499-509
15. Hunder GG, Bloch DA, Michel BA et al (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122-1128
16. Leavitt RY, Fauci AS, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 33:1101-1107
17. Lightfoot RW Jr, Michel BA, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 33:1088-1093
18. Luqmani RA, Bacon PA, Moots RJ et al (1994) Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. Q J Med 87:671-678
19. Luqmani RA, Exley AR, Kitas GD, Bacon PA (1997) Disease assessment and management of the vasculitides. Baillieres Clin Rheumatol 11(2):423-446
20. Maaser C, Eckmann L, Paesold G et al (2002) Ubiquitous production of macrophage migration inhibitory factor by human gastric and intestinal epithelium. Gastroenterology 122:667-680
21. Maksimowicz-Mc Kinnon K, Bhatt DL, Calabrese LH (2004) Recent advances in vascular inflammation: C-reactive protein and other inflammatory biomarkers. Curr Opin Rheumatol 16:18-24
22. Schmitt WH, van der Woude F (2004) Clinical application of antineutrophil cytoplasmic antibody testing. Curr Opin Rheumatol 16:9-17
23. Muller Kobold AC, Kallenberg CGM, Cohen Tervaert JW (1999) Monocyte activation in patients with Wegener's granulomatosis. Ann Rheum Dis 58:237-245
24. Lamprecht P, Kumanovics G, Mueller A et al (2002) Elevated monocytic IL-12 and TNF-alpha production in Wegener's granulomatosis is normalized by cyclophosphamide and corticosteroid therapy. Clin Exp Immunol 128:181-186
25. Komosci A, Lamprecht P, Csernok E et al (2002) Peripheral blood and granuloma CD4(+)CD28(-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosis. Am J Pathol 160(5):1717-1724
26. Czernok E, Trabandt A, Mueller A et al (1999) Cytokine profiles in Wegener's granulomatosis. Arthritis Rheum 42:742-750
27. De Jong YP, Abadia-Molina AC, Satoskar AR et al (2001) Development of chronic colitis is dependent on the cytokine MIF. Nat Immunol 2:1061-1066
28. Stavitsky AB, Xianli J (2002) In vitro and in vivo regulation of macrophage migration inhibitory factor (MIF) of expression of MHC-II, costimulatory, adhesion, receptor, and cytokine molecules. Cell Immunol 217(1-2):95-104
29. Park AY, Scott P (2001) IL-12: Keeping cell-mediated immunity alive. Scand J Immunol 53:529-532
30. Muller Kobold AC, van Wijk RT, Franssen CF et al (1999) In vitro up-regulation of E selectin and induction of interleukin-6 in endothelial cells by autoantibodies in Wegener's granulomatosis and microscopic polyangiitis. Clin Exp Rheumatol 17(4):433-440